GENENTECH ACTIVASE GROWTH SLOWED BY SHRINKING THROMBOLYTICS MARKET, FIRM SAYS: PFIZER ZITHROMAX SALES UP 75% ON SEVERE FLU SEASON, NEW INDICATIONS
Executive Summary
Genentech maintained a two-thirds share of the U.S. growth hormone market in 1996 with Protropin and Nutropin, the company said.